Evidence map›Paper›PMID 25927331›Full record

ArticleScientific reports2015

Raman spectroscopic sensing of carbonate intercalation in breast microcalcifications at stereotactic biopsy.

R Sathyavathi, Anushree Saha, Jaqueline S Soares, Nicolas Spegazzini, Sasha McGee, Ramachandra Rao Dasari, Maryann Fitzmaurice, Ishan Barman

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Raman active components of skin cancer.Biomedical optics express · 2017
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

R Sathyavathi1] Department of Pathology, School of Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA [2] Current Address: Sandor Lifesciences Pvt. Ltd, 8-2-326/5, Road No 3, Banjara Hills, Hyderabad-500034, India.
Anushree SahaDepartment of Pathology, School of Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA.
Jaqueline S SoaresDepartamento de Física, Universidade Federal de Ouro Preto, Ouro Preto, MG- 35400-000, Brazil.
Nicolas SpegazziniLaser Biomedical Research Center, G. R. Harrison Spectroscopy Laboratory, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
Sasha McGee1] Department of Pathology, School of Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA [2] Current Address: District of Columbia Department of Health, 899 North Capitol St NE, DC 20002, Washington.
Ramachandra Rao DasariLaser Biomedical Research Center, G. R. Harrison Spectroscopy Laboratory, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
Maryann FitzmauriceDepartment of Pathology, School of Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA.
Ishan Barman1] Department of Mechanical Engineering, Johns Hopkins University, Baltimore, Maryland 21218, USA [2] Department of Oncology, Johns Hopkins University, Baltimore, Maryland 21287, USA.

Funding

Wide-Field Short-Wave Infrared (SWIR) multiphoton (MP) tissue imagingP41EB015871 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SO, PETER T. · 2012 to 2021
$11.3M
Raman Spectroscopy for Guidance of Stereotactic Breast Biopsies for MicrocalcificR01CA140288 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI FITZMAURICE, MARYANN · 2009 to 2011
$1.0M
Acquisition of a Leica SCN400 Slide Scanning System For Use In A Multi-User FacilS10RR031845 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI CONRAD, PATRICIA A · 2011 to 2011
$377k
NCI NIH HHS R01 CA140288NCI NIH HHS R01-CA140288NCRR NIH HHS 1S10RR031845NCRR NIH HHS S10 RR031845NIBIB NIH HHS 9P41EB015871-27A1NIBIB NIH HHS P41 EB015871
6 · The paper itself

Abstract

Microcalcifications are an early mammographic sign of breast cancer and frequent target for stereotactic biopsy. Despite their indisputable value, microcalcifications, particularly of the type II variety that are comprised of calcium hydroxyapatite deposits, remain one of the least understood disease markers. Here we employed Raman spectroscopy to elucidate the relationship between pathogenicity of breast lesions in fresh biopsy cores and composition of type II microcalcifications. Using a chemometric model of chemical-morphological constituents, acquired Raman spectra were translated to characterize chemical makeup of the lesions. We find that increase in carbonate intercalation in the hydroxyapatite lattice can be reliably employed to differentiate benign from malignant lesions, with algorithms based only on carbonate and cytoplasmic protein content exhibiting excellent negative predictive value (93-98%). Our findings highlight the importance of calcium carbonate, an underrated constituent of microcalcifications, as a spectroscopic marker in breast pathology evaluation and pave the way for improved biopsy guidance.

Indexed as

AdultAgedBiopsyBreastBreast NeoplasmsCalcinosisCalcium CarbonateCarbonatesDurapatiteFemaleHumansIntercalating AgentsMiddle AgedSpectrum Analysis, RamanCalcium CarbonateCarbonatesDurapatiteIntercalating Agents

Identifiers

PMID25927331
PMCPMC4415591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.